Putative Role of β-1,3 Glucans in Candida albicans Biofilm Resistance
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Biofilms are microbial communities, embedded in a polymeric matrix, growing attached to a surface. Nearly all device-associated infections involve growth in the biofilm life style. Biofilm communities have characteristic architecture and distinct phenotypic properties. The most clinically important phenotype involves extraordinary resistance to antimicrobial therapy, making biofilm infections very difficulty to cure without device removal. The current studies examine drug resistance in Candida albicans biofilms. Similar to previous reports, we observed marked fluconazole and amphotericin B resistance in a C. albicans biofilm both in vitro and in vivo. We identified biofilm-associated cell wall architectural changes and increased β-1,3 glucan content in C. albicans cell walls from a biofilm compared to planktonic organisms. Elevated β-1,3 glucan levels were also found in the surrounding biofilm milieu and as part of the matrix both from in vitro and in vivo biofilm models. We thus investigated the possible contribution of β-glucans to antimicrobial resistance in Candida albicans biofilms. Initial studies examined the ability of cell wall and cell supernatant from biofilm and planktonic C. albicans to bind fluconazole. The cell walls from both environmental conditions bound fluconazole; however, four- to fivefold more compound was bound to the biofilm cell walls. Culture supernatant from the biofilm, but not planktonic cells, bound a measurable amount of this antifungal agent. We next investigated the effect of enzymatic modification of β-1,3 glucans on biofilm cell viability and the susceptibility of biofilm cells to fluconazole and amphotericin B. We observed a dose-dependent killing of in vitro biofilm cells in the presence of three different β-glucanase preparations. These same concentrations had no impact on planktonic cell viability. β-1,3 Glucanase markedly enhanced the activity of both fluconazole and amphotericin B. These observations were corroborated with an in vivo biofilm model. Exogenous biofilm matrix and commercial β-1,3 glucan reduced the activity of fluconazole against planktonic C. albicans in vitro. In sum, the current investigation identified glucan changes associated with C. albicans biofilm cells, demonstrated preferential binding of these biofilm cell components to antifungals, and showed a positive impact of the modification of biofilm β-1,3 glucans on drug susceptibility. These results provide indirect evidence suggesting a role for glucans in biofilm resistance and present a strong rationale for further molecular dissection of this resistance mechanism to identify new drug targets to treat biofilm infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, although β-1,3-glucans contribute to drug resistance and are the major cell wall polysaccharide (130), we now know that they constitute only a small fraction of the total polysaccharides present, implying that the matrix is not constructed simply of released cell wall constituents.”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One known constituent of the biofilm matrix that contributes to its drug-resistance properties is the polysaccharide β-1,3-glucan (130).”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Few studies have shown that fluconazole-resistant (FR) C. albicans may also exhibit higher levels of β-glucans compared to susceptible strains (12, 16).”
From Candida albicans enhances iron uptake to maintain fluconazole resistance (2025) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Higher levels of β-glucans absorb fluconazole and inhibit its penetration to the site of action (12).”
From Candida albicans enhances iron uptake to maintain fluconazole resistance (2025) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“β-glucans can act as a physical barrier, reducing the accessibility of fluconazole to its target sites in the cell membrane and limiting its effectiveness (12).”
From Candida albicans enhances iron uptake to maintain fluconazole resistance (2025) · cites this paper as [12]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Colorimetric Method for Determination of Sugars and Related Substances
DuBois, M., Gilles, K. A., Hamilton, J. K., Rebers, P. A., & Smith, F. (1956) · Analytical Chemistry · doi:10.1021/ac60111a017 · Cited by 52,269 · cited 1×
“Carbohydrate concentrations of each fraction were measured as hexoses by the phenol-sulfuric method as previously described (18, 22 , 40).”
MethodBacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167 · cited 1×
“Biofilms are structured microbial communities in which organisms irreversibly attach to a surface and become embedded in a matrix of extracellular polymeric substances produced by these cells (6, 15, 17 , 20, 21, 24, 41, 46, 50).”
BackgroundBiofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644 · cited 1×
“Biofilms are structured microbial communities in which organisms irreversibly attach to a surface and become embedded in a matrix of extracellular polymeric substances produced by these cells (6, 15, 17, 20 , 21, 24, 41, 46, 50).”
BackgroundMechanisms of biofilm resistance to antimicrobial agents
Mah, T.-F. C., & O'Toole, G. A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01913-2 · Cited by 3,921 · cited 2×
“Previous studies in a bacterial biofilm model demonstrated sequestration of antimicrobial compounds by a cell wall component, specifically, the -1,3 glucan component of biofilm cells (33, 34 ).”
BackgroundMethods in yeast genetics : a Cold Spring Harbor Laboratory course manual
Amberg, D. C., Burke, D. J., & Strathern, J. N. (2005) · Cited by 1,803
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578 · cited 1×
“25 g/ml for fluconazole and amphotericin B, respectively [2, 6, 7, 9, 11, 15, 25, 30, 31, 47].”
BackgroundGuidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440 · cited 3×
“C. albicans is a major human pathogen which can grow as a biofilm and inhabit the surface of many medical devices (28, 44 ).”
BackgroundInfluentialClinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353 · cited 1×
“A number of molecular mechanisms have been implicated in nonbiofilm antifungal resistance in C. albicans ( 54 ).”
BackgroundA genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance
Mah, T.-F., Pitts, B., Pellock, B., Walker, G. C., Stewart, P. S., & O'Toole, G. A. (2003) · Nature · doi:10.1038/nature02122 · Cited by 1,190
Candida biofilms and their role in infection
Douglas, L. J. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(02)00002-1 · Cited by 1,150 · cited 2×
“Biofilms are the most common form of microbial growth in nature, and the National Institutes of Health estimate that biofilms cause the majority of infections in humans ( 21 , 28, 45, 46).”
Background
Research works printed but not linked: 1
- 19. Dijkgaraff, G. J. P., J. L. Brown, and H. Bussey. 1996. The KHN1 gene of Saccharomyces cerevisiae is a functional homolog of KRE9 . Yeast. 12: 683692. · DOI · Paper page
Cited by
Items 101–200 of 414
A Histone Deacetylase Complex Mediates Biofilm Dispersal and Drug Resistance in Candida albicans
Nobile, C. J., Fox, E. P., Hartooni, N., Mitchell, K. F., Hnisz, D., Andes, D. R., Kuchler, K., & Johnson, A. D. (2014) · mBio · doi:10.1128/mbio.01201-14 · Cited by 87
Self-citationMesa-Arango, A. C., Rueda, C., Román, E., Quintin, J., Terrón, M. C., Luque, D., Netea, M. G., Pla, J., & Zaragoza, O. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02681-15 · Cited by 86
Comparative analysis of Candida biofilm quantitation assays
Taff, H. T., Nett, J. E., & Andes, D. R. (2012) · Medical Mycology · doi:10.3109/13693786.2011.580016 · Cited by 80
Self-citationKhoury, Z. H., Vila, T. V. M., Puthran, T. R., Sultan, A. S., Montelongo‐Jauregui, D., Melo, M. A. S., & Jabra‐Rizk, M. A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00307 · Cited by 90
“The C. albicans biofilm matrix is complex and largely composed of polysaccharides such as β-1,3-glucan, β-1,6-glucan, and mannans which form the mannan–glucan complex (MGCx) (Al-Fattani and Douglas, 2006; Nett et al., 2007; Nett et al., 2011; Mitchell et al., 2015).”
BackgroundFerreira, J. A. G., Carr, J. H., Starling, C. E. F., de Resende, M. A., & Donlan, R. M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00316-09 · Cited by 84
“albicans biofilm cell walls contain significantly higher concentrations of -1,3-glucan than their planktonic counterparts, and these glucans can be found in the supernatant surrounding the biofilm and in the matrix (41).”
BackgroundThe effect of biomaterials and antifungals on biofilm formation by Candida species: a review
Cuéllar‐Cruz, M., Vega‐González, A., Mendoza‐Novelo, B., López-Romero, E., Ruiz‐Baca, E., Escorza, M. A. Q., & Villagómez-Castro, J. C. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1634-6 · Cited by 104
“This matrix provides the distribution of nutrients, while serving as a barrier to the diffusion of antifungals to the interior of the biofilm [42, 56–60].”
BackgroundQu, Y., Locock, K. E. S., Verma‐Gaur, J., Hay, I. D., Meagher, L., & Traven, A. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv334 · Cited by 84
Hiller, E., Heine, S., Brunner, H., & Rupp, S. (2007) · Eukaryotic Cell · doi:10.1128/ec.00285-07 · Cited by 82
Ansari, M. A., & Asiri, S. M. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.12.162 · Cited by 80
Future directions for anti-biofilm therapeutics targetingCandida
Nett, J. E. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.885838 · Cited by 96
“For example, digestion of b-1,3 glucan potentiated fluconazole activity while degradation of eDNA enhanced amphotericin B activity in vitro [25,35,42].”
BackgroundSelf-citationHorton, M. V., Johnson, C. J., Zarnowski, R., Andes, B. D., Schoen, T. J., Kernien, J. F., Lowman, D., Kruppa, M. D., Ma, Z., Williams, D. L., et al. (2021) · mSphere · doi:10.1128/msphere.00406-21 · Cited by 79
Self-citationVisualized Gallium/Lyticase‐Integrated Antifungal Strategy for Fungal Keratitis Treatment
He, J., Ye, Y., Zhang, D., Yao, K., & Zhou, M. (2022) · Advanced Materials · doi:10.1002/adma.202206437 · Cited by 90
Reduced Biocide Susceptibility in Candida albicans Biofilms
Nett, J. E., Guite, K. M., Ringeisen, A., Holoyda, K. A., & Andes, D. R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01656-07 · Cited by 72
Self-citationFungal biofilms in human health and disease
Ramage, G., Kean, R., Rautemaa-Richardson, R., Williams, C., & Lopez-Ribot, J. L. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01147-0 · Cited by 72
“Surrounded and encased by a protective self-produced exopolymeric matrix, this environment provides a protective barrier to physical and chemical agents that could potentially injure or kill cells 8 .”
Hydrodynamic effects on bacterial biofilm development in a microfluidic environment
Kim, J., Kim, H.-S., Han, S., Lee, J.-Y., Oh, J.-E., Chung, S. H., & Park, H. (2013) · Lab on a Chip · doi:10.1039/c3lc40802g · Cited by 72
Zhou, Y., Wang, G., Li, Y., Liu, Y., Song, Y., Zheng, W., Zhang, N., Hu, X., Yan, S., & Jia, J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06082-11 · Cited by 72
“albicans biofilm is a heterogeneous community of yeast, pseudohyphal, and hyphal cells embedded in an extracellular polymeric matrix, noticeably including soluble -glucans (28).”
BackgroundScarsini, M., Tomasinsig, L., Arzese, A., D’Este, F., Oro, D., & Skerlavaj, B. (2015) · Peptides · doi:10.1016/j.peptides.2015.07.023 · Cited by 72
Beauvais, A., Loussert, C., Prevost, M. C., Verstrepen, K., & Latgé, J. P. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00482.x · Cited by 68
Identification of novel mechanisms involved in generating localized vulvodynia pain
Falsetta, M. L., Foster, D. C., Woeller, C. F., Pollock, S. J., Bonham, A. D., Haidaris, C. G., Stodgell, C. J., & Phipps, R. P. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.02.002 · Cited by 69
Fungal Biofilms: Update on Resistance
Borghi, E., Borgo, F., & Morace, G. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_7 · Cited by 76
Resistance of Candida albicans Biofilms to Drugs and the Host Immune System
Sandai, D. A., Tabana, Y., Ouweini, A. E., & Ishola, O. A. (2016) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.37385 · Cited by 77
Monteiro, D. R., Silva, S. M., Negri, M., Gorup, L. F., Camargo, E. R., Oliveira, R., Barbosa, D. B., & Henriques, M. (2013) · Journal of Applied Microbiology · doi:10.1111/jam.12102 · Cited by 83
“albicans is composed by 80 to 90% of carbohydrates, and the most frequently found are b-glucans (Nett et al. 2007; Paramonova et al. 2009).”
BackgroundHost Contributions to Construction of Three Device-Associated Candida albicans Biofilms
Nett, J. E., Zarnowski, R., Cabezas-Olcoz, J., Brooks, E. G., Bernhardt, J., Marchillo, K., Mosher, D. F., & Andes, D. R. (2015) · Infection and Immunity · doi:10.1128/iai.00931-15 · Cited by 67
Self-citationAssessment and Optimizations of Candida albicans In Vitro Biofilm Assays
Lohse, M. B., Gulati, M., Valle Arevalo, A., Fishburn, A., Johnson, A. D., & Nobile, C. J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02749-16 · Cited by 66
Fungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm Drugs
Nett, J. E., & R. Andes, D. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0008-2014 · Cited by 60
Self-citationTime Course Analysis of Candida albicans Metabolites during Biofilm Development
Zhu, Z., Wang, H., Shang, Q., Jiang, Y., Cao, Y., & Chai, Y. (2013) · Journal of Proteome Research · doi:10.1021/pr300447k · Cited by 66
Biofilm formation on denture liners in a randomised controlled in situ trial
Valentini, F., Luz, M. S., Boscato, N., & Pereira‐Cenci, T. (2013) · Journal of Dentistry · doi:10.1016/j.jdent.2013.02.012 · Cited by 77
Increase of Virulence and Its Phenotypic Traits in Drug-Resistant Strains of Candida albicans
Angiolella, L., Stringaro, A. R., De Bernardis, F., Posteraro, B., Bonito, M., Toccacieli, L., Torosantucci, A., Colone, M., Sanguinetti, M., Cassone, A., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01223-07 · Cited by 64
“albicans cells to FLC by binding this drug extracellularly (30).”
BackgroundMedically Important Fungi Respond to Azole Drugs: An Update
Zavřel, M., & White, T. C. (2015) · Future Microbiology · doi:10.2217/fmb.15.47 · Cited by 69
Foster, D. C., Falsetta, M. L., Woeller, C. F., Pollock, S. J., Song, K., Bonham, A., Haidaris, C. G., Stodgell, C. J., Messing, S. P., Iadarola, M., et al. (2015) · Pain · doi:10.1097/01.j.pain.0000460320.95267.5d · Cited by 63
Antifungal drug resistance in Candida: a special emphasis on amphotericin B
Ahmady, L., Gothwal, M., Mukkoli, M. M., & Bari, V. K. (2024) · Apmis · doi:10.1111/apm.13389 · Cited by 65
Genetic basis of antifungal drug resistance
Marie, C., & White, T. C. (2009) · Current Fungal Infection Reports · doi:10.1007/s12281-009-0021-y · Cited by 57
Candida albicans enhances meropenem tolerance of Pseudomonas aeruginosa in a dual-species biofilm
Alam, F., Catlow, D., Maio, A. D., Blair, J. M. A., & Hall, R. A. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz514 · Cited by 65
Advances in Biomaterials for the Prevention and Disruption of Candida Biofilms
Vera‐González, N., & Shukla, A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.538602 · Cited by 67
LaFleur, M. D., Lucumi, E., Napper, A. D., Diamond, S. L., & Lewis, K. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq530 · Cited by 59
Chong, P., Chin, V., Wong, W., Madhavan, P., Yong, V., & Looi, C. (2018) · Genes · doi:10.3390/genes9110540 · Cited by 57
“One of the more prominent factors is the ability of this species to effectively pump out drugs via its efflux pumps mechanism [41].”
BackgroundRat Indwelling Urinary Catheter Model of Candida albicans Biofilm Infection
Nett, J. E., Brooks, E. G., Cabezas-Olcoz, J., Sanchez, H., Zarnowski, R., Marchillo, K., & Andes, D. R. (2014) · Infection and Immunity · doi:10.1128/iai.02284-14 · Cited by 58
Self-citationThe Clinical Importance of Fungal Biofilms
Ramage, G., & Williams, C. (2013) · Advances in applied microbiology · doi:10.1016/b978-0-12-407673-0.00002-3 · Cited by 62
Biofilm formation in Candida glabrata: What have we learnt from functional genomics approaches?
d'Enfert, C., & Janbon, G. (2016) · FEMS Yeast Research · doi:10.1093/femsyr/fov111 · Cited by 53
“Little is known about the composition of the C. glabrata biofilm matrix except that it includes proteins and carbohydrates, among which β1,3-glucans (Nett et al. 2007a; Silva et al. 2009).”
BackgroundGaining Insights from Candida Biofilm Heterogeneity: One Size Does Not Fit All
Kean, R., Delaney, C., Rajendran, R., Sherry, L., Metcalfe, R., Thomas, R., McLean, W., Williams, C., & Ramage, G. (2018) · Journal of Fungi · doi:10.3390/jof4010012 · Cited by 55
“Therefore, the output achiev d from XTT is only cellular viability and it does not take into account other biofilm components such as the extracellular m trix (ECM), which are arguably the most important when it comes t biofilms [12].”
BackgroundRole of Exopolysaccharides in Biofilm Formation
Gupta, P., Pruthi, P. A., & Pruthi, V. (2019) · ACS symposium series · doi:10.1021/bk-2019-1323.ch002 · Cited by 76
The Effects of β -Glucans on Dendritic Cells and Implications for Cancer Therapy
Albeituni, S., & Yan, J. (2013) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520611313050003 · Cited by 55
Bergamo, V. Z., Donato, R. K., Lana, D. F. D., Donato, K. J. Z., Ortega, G. G., Schrekker, H. S., & Fuentefría, A. M. (2014) · Letters in Applied Microbiology · doi:10.1111/lam.12338 · Cited by 70
“This causes a slow diffusion of the antimicrobial agents into the extracellular matrix water channels, hindering their access to the target fungal cells inside the biofilm biomass (Gordon et al. 1988; Kumamoto 2002; Nett et al. 2007).”
BackgroundPais, P., Galocha, M., Viana, R., Cavalheiro, M., Pereira, D., & Teixeira, M. C. (2019) · Microbial Cell · doi:10.15698/mic2019.03.670 · Cited by 51
“Although very simply described herein, the formation of Candida biofilms is a very complex process which relies on different mechanisms, such as cell-tocell adhesion, crucial for the integrity of the biofilm [113], or the formation of the ECM, composed by different EPS, some identified as important for the resistance…”
BackgroundVila, T. V. M., Ishida, K., Seabra, S. H., & Rozental, S. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.07.022 · Cited by 54
“Recovered Candida spp. biofilm cells are susceptible to miltefosine To elucidate the role of the biofilm three-dimensional structure in the susceptibility to miltefosine and the standard antifungals, control and pre-treated biofilm cells were recovered and their susceptibility to antifungals was tested after the ECM w…”
BackgroundMethodInfluentialLife on a leaf: the epiphyte to pathogen continuum and interplay in the phyllosphere
Thomas, G., Kay, W. T., & Fones, H. N. (2024) · BMC Biology · doi:10.1186/s12915-024-01967-1 · Cited by 54
The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida
Lewis, R. E., Viale, P., & Kontoyiannis, D. P. (2012) · Virulence · doi:10.4161/viru.20746 · Cited by 46
Role of the extracellular matrix in Candida biofilm antifungal resistance
Massey, J., Żarnowski, R., & Andes, D. R. (2023) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuad059 · Cited by 52
Self-citationSaccharomyces cerevisiae biofilm tolerance towards systemic antifungals depends on growth phase
Bojsen, R., Regenberg, B., & Folkesson, A. (2014) · BMC Microbiology · doi:10.1186/s12866-014-0305-4 · Cited by 44
“Treatment of biofilm cells with glucanases or DNase result in increased efficacy of antifungal agents, which indicate a role of ECM on antifungal drug tolerance [13,14].”
BackgroundResultDevelopment of a High-Throughput Candida albicans Biofilm Chip
Srinivasan, A., Uppuluri, P., Lopez-Ribot, J., & Ramasubramanian, A. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019036 · Cited by 47
Panariello, B. H. D., Klein, M. I., Pavarina, A. C., & Duarte, S. (2017) · Journal of Oral Microbiology · doi:10.1080/20002297.2017.1385372 · Cited by 51
“which bind to fluconazole [13] and amphotericin B, preventing the penetration of drugs into the biofilm [14].”
BackgroundTsai, P.-W., Yang, C.-Y., Chang, H.-T., & Lan, C.-Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021394 · Cited by 47
The Host’s Reply to Candida Biofilm
Nett, J. (2016) · Pathogens · doi:10.3390/pathogens5010033 · Cited by 47
“These adherent communities exhibit characteristics distinct from free-floating or planktonic cells, including the ability to tolerate high antifungal concentrations and to evade host immune detection [3–6].”
BackgroundSelf-citationRole of SFP1 in the Regulation of Candida albicans Biofilm Formation
Chen, H.-F., & Lan, C.-Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0129903 · Cited by 43
Biofilm-Associated Candidiasis: Pathogenesis, Prevalence, Challenges and Therapeutic Options
Amann, V., Kissmann, A., Firacative, C., & Rosenau, F. (2025) · Pharmaceuticals · doi:10.3390/ph18040460 · Cited by 48
“In addition, the ECM has been shown to have the ability to bind or sequester various drugs and develop resistance to these [162,212–215].”
El-Azizi, M., Farag, N. S., & Khardori, N. M. (2015) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-015-0083-3 · Cited by 50
“Up to 70–80% of Candida bloodstream infections are associated with central venous catheters, and the majority of Candida urinary tract infections are associated with indwelling urinary catheters [12].”
Recent developments on using nanomaterials to combat Candida albicans
Li, B., Pan, L., Zhang, H., Xie, L., Wang, X., Shou, J., Qi, Y., & Yan, X. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.813973 · Cited by 43
“It has been observed that the thickness of the biofilm is twice that of free cells (Nett et al., 2007; Lima et al., 2019).”
BackgroundCandida albicans virulence and drug-resistance requires the O-acyltransferase Gup1p
Ferreira, C., Silva, S. M., Faria‐Oliveira, F., Pinho, E., Henriques, M., & Lucas, C. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-238 · Cited by 58
“biofilm cells has been ascribed to b-1,3- glucans [ 61 ].”
BackgroundInfluentialAntibiofilm activity of quercetin-encapsulated cytocompatible nanofibers against Candida albicans
Vashisth, P., Nikhil, K., Pemmaraju, S. C., Pruthi, P. A., Mallick, V., Singh, H., Patel, A., Mishra, N. C., Singh, R. P., & Pruthi, V. (2013) · Journal of Bioactive and Compatible Polymers · doi:10.1177/0883911513502279 · Cited by 49
“654 Journal of Bioactive and Compatible Polymers 28(6)”
BackgroundInfluentialBojsen, R., Regenberg, B., Gresham, D., & Folkesson, A. (2016) · Scientific Reports · doi:10.1038/srep21874 · Cited by 42
Xia, J., Qian, F., Xu, W., Zhang, Z., & Wei, X. (2017) · Biofouling · doi:10.1080/08927014.2017.1295304 · Cited by 43
“Biofilms were then stained with 500 μl of calcofluor white stain (Nett et al. 2007) (0.0025 g ml−1; Sigma Chemical Co.) for 30 min at 37°C in the dark and observed with a Zeiss LSM700 microscope with a video capture system, automatic camera, image analysis hardware and software (Carl Zeiss, Inc.,…”
MethodInfluentialThe role of flow in bacterial biofilm morphology and wetting properties
Recupido, F., Toscano, G., Tatè, R., Petala, M. D., Caserta, S., Karapantsios, T. D., & Guido, S. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.111047 · Cited by 46
de Souza, L. B. F. C., Rocha, W. P. D. S., Ferreira, M. R. A., Soares, L. A. L., Svidzinski, T. I. E., Milan, E. P., Pires, R. H., Fusco‐Almeida, A. M., Mendes‐Giannini, M. J. S., & Chaves, G. M. (2018) · Molecules · doi:10.3390/molecules23102418 · Cited by 45
“Perhaps the most clinically relevant biofilm-specific property is the development of antifungal resistance of cells composing it, where minimal inhibitory concentrations (MICs) can be up to 1000-fold higher than those found for planktonic cells [16,17].”
BackgroundKahl, L. J., Stremmel, N., Esparza-Mora, M. A., Wheatley, R. M., MacLean, R. C., & Ralser, M. (2023) · Current Opinion in Microbiology · doi:10.1016/j.mib.2023.102368 · Cited by 44
Fungal Biofilm Composition and Opportunities in Drug Discovery
Reichhardt, C., Stevens, D. A., & Cegelski, L. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0049 · Cited by 36
Xu, Z., Huang, T., Du, ., Soteyome, T., Lan, H., Hong, W., Peng, F., Fu, X., Peng, G., Liu, J., et al. (2021) · Bioengineered · doi:10.1080/21655979.2021.1996747 · Cited by 39
RetractedKumar, R., & Shukla, P. (2009) · Fungal Biology · doi:10.1016/j.funbio.2009.12.003 · Cited by 41
What Makes Oral Candidiasis Recurrent Infection? A Clinical View
Darwazeh, A. M.-G., & Darwazeh, T. (2014) · Journal of Mycology · doi:10.1155/2014/758394 · Cited by 39
“The lower toxicity of clinically used antifungals, such as amphotericin B and fluconazole, to biofilm cells is due to extracellular matrix adsorption of drugs [24] and formation of “persister” cells [25].”
BackgroundTan, Y., Ma, S., Leonhard, M., Moser, D., & Schneider‐Stickler, B. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.11.003 · Cited by 40
Panariello, B. H. D., Klein, M. I., Mima, E. G. D. O., & Pavarina, A. C. (2018) · Journal of Oral Microbiology · doi:10.1080/20002297.2018.1476644 · Cited by 41
Distorted Gold(I)–Phosphine Complexes as Antifungal Agents
Dennis, E. K., Kim, J. H., Parkin, S., Awuah, S. G., & Garneau‐Tsodikova, S. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01436 · Cited by 39
Microbial cell surface proteins and secreted metabolites involved in multispecies biofilms
Demuyser, L., Jabra‐Rizk, M. A., & Dijck, P. V. (2014) · Pathogens and Disease · doi:10.1111/2049-632x.12123 · Cited by 43
Divya, M., Karthikeyan, S., Ravi, C., Govindarajan, M., Alharbi, N. S. H. A., Kadaikunnan, S., Khaled, J. M. A., Almanaa, T. N., & Vaseeharan, B. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.103955 · Cited by 36
Tian, B., Yan, Q., Wang, J., Ding, C., & Sai, S. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s145695 · Cited by 37
Tebbets, B., Stewart, D. A., Lawry, S. M., Nett, J. E., Nantel, A., Andes, D. R., & Klein, B. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036021 · Cited by 36
Self-citationFungal Metabolites for the Control of Biofilm Infections
Estrela, A. B., & Abraham, W. (2016) · Agriculture · doi:10.3390/agriculture6030037 · Cited by 37
Huang, M.-C., Shen, M., Huang, Y.-J., Lin, H.-C., & Chen, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020434 · Cited by 36
“[41] further demonstrated that β-1,3-glucans, the major component of EPS in C.”
BackgroundDNase increases the efficacy of antimicrobial photodynamic therapy on Candida albicans biofilms
Panariello, B. H. D., Klein, M. I., Alves, F., & Pavarina, A. C. (2019) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2019.05.038 · Cited by 34
Expression of CgCDR1,CgCDR2, and CgERG11 in Candida glabrata biofilms formed by bloodstream isolates
Song, J. W., Shin, J. H., Kee, S. J., Kim, S. H., Shin, M. G., Suh, S. P., & Ryang, D. W. (2009) · Medical Mycology · doi:10.1080/13693780802210726 · Cited by 32
Resistance to antifungal therapies
Prasad, R., Banerjee, A., & Shah, A. H. (2017) · Essays in Biochemistry · doi:10.1042/ebc20160067 · Cited by 37
Graphene oxide based ion-imprinted polymers for selective uranium adsorption from seawater
Zhu, J., Zhao, L., Song, D., Yu, J., Liu, Q., Liu, J., Chen, R., & Wang, J. (2023) · Applied Surface Science · doi:10.1016/j.apsusc.2023.158378 · Cited by 34
Nanoscale Surface Roughness Influences Candida albicans Biofilm Formation
Le, P. H., Nguyen, H., Aburto‐Medina, A., Linklater, D. P., Crawford, R. J., MacLaughlin, S. A., & Ivanova, E. P. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00985 · Cited by 34
Experimental Biofilm-Related Candida Infections
Cirasola, D., Sciota, R., Vizzini, L., Ricucci, V., Morace, G., & Borghi, E. (2013) · Future Microbiology · doi:10.2217/fmb.13.36 · Cited by 36
Kanaguchi, N., Narisawa, N., Ito, T., Kinoshita, Y., Kusumoto, Y., Shinozuka, O., & Senpuku, H. (2012) · BMC Oral Health · doi:10.1186/1472-6831-12-36 · Cited by 34
“A clinically significant characteristic of microbial biofilms is their enhanced resistance to antimicrobial drug therapies [10-12].”
BackgroundPrevention of Candida albicans Biofilm Formation
Coenye, T. (2011) · The Open Mycology Journal · doi:10.2174/1874437001105010009 · Cited by 36
“In addition, matrix components may also bind antimicrobial agents directly [12-14].”
BackgroundPereira, L., Silva, S. M., Ribeiro, B., Henriques, M., & Azeredo, J. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov043 · Cited by 37
“The extracellular β -1,3 glucan, has been linked to overall matrix production and drug resistance is catalysed by β-1,3 glucan synthase (GS1) and the gene FKS1 is responsible for the catalytic subunit of β-1,3 glucan synthase (Nett et al., 2007; Nett et al., 2010; Taff et al., 2012), which substrate is glucose.”
Rodrigues, C. F., & Henriques, M. (2018) · Genes · doi:10.3390/genes9040205 · Cited by 32
“Interestingly, it has been demonstrated that an increase in cell wall glucan was associated with biofilm growth [14] and, more recently, β-1,3 glucans were shown to be also present in the matrices of C.”
BackgroundFuture therapies targeted towards eliminatingCandidabiofilms and associated infections
Bandara, N., Matsubara, V. H., & Samaranayake, L. P. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1268530 · Cited by 41
Advancements and Potential Applications of Microfluidic Approaches—A Review
Ahmed, I., Akram, Z., Bule, M. H., & Iqbal, H. M. N. (2018) · Chemosensors · doi:10.3390/chemosensors6040046 · Cited by 30
Pentland, D. R., Davis, J., Mühlschlegel, F. A., & Gourlay, C. W. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-021-00238-z · Cited by 28
Voriconazole inhibits biofilm formation in different species of the genus Candida
Valentín, A., Cantón, R., Pemán, J., & Martinez, J. P. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks242 · Cited by 31
Management of Candida Biofilms: State Of Knowledge and New Options for Prevention and Eradication
Bujdáková, H. (2016) · Future Microbiology · doi:10.2217/fmb.15.139 · Cited by 37
Shao, J., Cui, Y., Zhang, M.-X., Wang, T., Wu, D., & Wang, C. (2016) · Pharmaceutical Biology · doi:10.1080/13880209.2016.1237977 · Cited by 29
“As described previously, b-1,3-glucan in cell wall could nonspecifically interact with fluconazole to prevent from penetration into fungal cell (Nett et al. 2007), conferring partly a resistance to fluconazole in C. albicans.”
BackgroundSingh, R., Kumari, A., Kaur, K., Sethi, P., & Chakrabarti, A. (2018) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000757 · Cited by 27
Optimized platform for automated glycan assembly
Danglad‐Flores, J., Sletten, E. T., Reuber, E. E., Bienert, K., Riegler, H. E., & Seeberger, P. H. (2024) · Device · doi:10.1016/j.device.2024.100499 · Cited by 26
Mazumder, S., Bhattacharya, D., Lahiri, D., Moovendhan, M., Sarkar, T., & Nag, M. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2417801 · Cited by 26
“Therefore, the biofilm and its matrix are destroyed when the concentration is changed to a greater concentration (Nett et al. 2007).”
Setiawati, S., Nuryastuti, T., Ngatidjan, N., Mustofa, M., Jumina, J., & Fitriastuti, D. (2017) · Mycobiology · doi:10.5941/myco.2017.45.1.25 · Cited by 28
“Some studies have suggested that the 1,10-phenanthroline complex targets cells by disrupting the mitochondria, inducing oxidative stress, and interfering with cell respiration, which results in changes to the structures of the cells, which eventually undergo apoptosis [15, 24].”
BackgroundZainab, S., Hamid, S., Sahar, S., & Ali, N. (2021) · Materials Chemistry and Physics · doi:10.1016/j.matchemphys.2021.125451 · Cited by 31
Tati, S., Jang, W. S., Li, R. Q., Kumar, R., Puri, S., & Edgerton, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061480 · Cited by 29
Sadanandan, B., Vijayalakshmi, V., Lokesh, K. N., Shetty, K., Joglekar, A. P., Ashrit, P., & Hemanth, B. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.15402 · Cited by 25
“The absorbance was measured using microplate reader (Synergy HT, Biotek) at 492 nm (Nett et al., 2007).”
Method
Metadata
- Authors
- Nett, J., Lincoln, L., Marchillo, K., Massey, R., Holoyda, K., Hoff, B., VanHandel, M., & Andes, D.
- Affiliations
- University of Wisconsin–Madison (US)
- Departments of Medicine and Medical Microbiology and Immunology
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2007-02
- Volume
- 51
- Issue
- 2
- Pages
- 510-520
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC1797745
- OpenAlex
- W1999751604
- Cited by
- 407
- References
- 55
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 19 · 2023: 22 · 2022: 20 · 2021: 15 · 2020: 26 · 2019: 19 · 2018: 22 · 2017: 34 · 2016: 26 · 2015: 28 · 2014: 25 · 2013: 20 · 2012: 23
- FWCI
- 7.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (T32HL007899)
- National Institute of Allergy and Infectious Diseases (R01AI073289)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- Candida albicans, biofilm, β-1,3-glucan, antifungal resistance, fluconazole resistance, amphotericin B resistance, β-glucanase, cell wall architecture, biofilm matrix, planktonic versus biofilm cells, device-related infection, antifungal susceptibility testing
- MeSH terms
- Amphotericin B, Antifungal Agents, Candida albicans, Microbial Sensitivity Tests, Fluconazole, Biofilms, Drug Resistance, Fungal, Glucan 1,3-beta-Glucosidase, beta-Glucans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.